l-carnitine modulates free mitochondrial DNA DAMPs and platelet storage lesions during storage of platelet concentrates

• Published in: Journal of thrombosis and thrombolysis 2023-01, Vol.55 (1), p.60-66
• Main Authors: Bagheri, Saeede, Samiee, Shahram, Zarif, Mahin Nikougoftar, Deyhim, Mohammad Reza
• Format: Article
• Language: English
• Subjects: Antioxidants; Antioxidants - metabolism; Antioxidants - pharmacology; Blood Platelets; Blood Preservation - methods; Cardiology; Carnitine; Carnitine - pharmacology; DNA damage; DNA, Mitochondrial; Enzymatic activity; Hematology; Humans; L-Lactate dehydrogenase; Lactic acid; Medicine; Medicine & Public Health; Mitochondrial DNA; Platelets; Reactive oxygen species; Reactive Oxygen Species - metabolism
• ISSN: 1573-742X; 0929-5305; 1573-742X
• DOI: 10.1007/s11239-022-02725-2

Platelet storage lesions may occur in Platelet concentrates (PCs) storage time, reducing PCs' quality. Mitochondrial damage causes mitochondrial DNA (mtDNA) to be released into the extracellular space. In this study, we evaluated the effect of l -carnitine (LC) as an antioxidant on free mtDNA DAMPs release in PCs during storage. Ten PCs prepared by the PRP method were studied. The copy numbers of free mtDNA, total reactive oxygen species (ROS), lactate dehydrogenase (LDH) enzyme activity, pH, and platelet counts were measured on days 0, 3, 5, and 7 of PCs storage in LC-treated and untreated platelets. LDH activity was significantly lower than the control group during 7 days of PCs storage (p = 0.041). Also, ROS production decreased in LC-treated PCs compared to the control group during storage (p = 0.026), and the difference mean of ROS between the two groups was significant on day 3, 5, and 7 (P day3  = 0.02, P day5  = 0.0001, P day7  = 0.031). Moreover, LC decreased the copy numbers of free mtDNA during 7 days of storage (p = 0.021), and the difference mean of the copy numbers of free mtDNA in LC-treated PCs compared to the control group was significant on day 5 and 7 (P day5  = 0.041، P day7  = 0.022). It seems that LC can maintain the metabolism and antioxidant capacity of PCs and thus can reduce mitochondrial damage and mtDNA release; consequently, it can decrease DAMPs in PCs. Therefore, it may be possible to use this substance as a platelet additive solution in the future.